The Shy-Drager syndrome is a rare neurological disorder of multiple system atrophy originally described to consist of progressive generalized autonomic failure and extrapyramidal and/or cerebellar dysfunction'. However, it is not sufficiently appreciated that other features including vocal cord paralysis2, speech3-5, sleep6 and psychiatric changes7'8 have more recently, but separately, been described. We report a patient who demonstrated some of the clinical diversity and diagnostic pitfalls that can occur.
Case report A 54-year-old male Chinese farmer was admitted to a medical ward after 3 months of severe postural dizziness and recurrent syncope. There was a history of the progressive development of impotence and loss of libido for 5 years, urinary incontinence, incomplete emptying of the bladder, severe 'snoring', fatiguability, diarrhoea followed by constipation for 2 years, lack ofsweating in hot weather and change of voice for 2 months.
Examination showed a severe postural drop in blood pressure (supine 150/95 to standing 70/50) associated with no compensatory rise in pulse rate. Right facial hypohidrosis, reduced anal tone, mild dysarthria and a noisy stridor during sleep were detected. Extrapyramidal features were absent.
A provisional diagnosis of generalized autonomic neuropathy was made and led to extensive investigations in search for an underlying cause. However, the complete blood picture, erytbrocyte sedimentation rate, renal and liver function tests, blood tests for venereal disease, follicle stimulating hormone, luteinizing hormone (for his impotence), prostatic acid phosphatase (for 'prostatic hypertrophy' according to a surgical opinion), cardiac enzymes, serum protein electrophoresis and rectal biopsy (for amyloidosis) all turned out to be normal. As regards the stridor, flexible laryngoscopy revealed bilateral abductor paralysis of the vocal cords so that barium swallow and computed tomography scan of mediastinum and of the brain were performed but were normal. The patient was finally diagnosed as 'idiopathic autonomic neuropathy' with the vocal cord paralysis being 'difficult to account for'. Treatment with oral fludrocortisone (0.2 mg daily) and psure garment only gave slight relieffrom the progressively severe dizziness. Two months later, the patient was referred to our sleep disorders clinic for assessment of oxygen desaturation during sleep and of the possibility of sleep apnoea. At this point he complained of one month's history of right-sided clumsiness. Examination showed that besides dysarthria, he had right-sided cerebellar dysfunction in the form of dysmetria, dysdiadochokinesia and a persistent tendency to fall towards the right side on heel-toe walking. Parkinsonism features were completely absent. The standing diastolic blood pressure was unrecordable. Psychiatrically, he had mild depressive feelings over the relentless disease but this did not amount to a clinical depressive disorder. His cognitive functions were satisfactory.
Nocturnal polysomnogram showed reductions in total sleep time (5% h), slow wave (5.2%) and rapid eye movement (8.2%) sleep. The oxygen saturation was between 70 and 80% and the respiratory rate reached a maximum of 50/min. But apnoeic or hypopnoeic episodes were entirely absent. The physical and psychological complicationis of a tracheostomy again deterred him from the operation. He died suddenly during sleep in the early morning (about 0500 h) of the next day. His relatives refused a postmortem.
Discussion
This patient evidently had overinvestigations and a delay in diagnosis. His symptom complex of autonomic dysfunction was not an atypical one9, but his cerebellar signs arose much later, in contrast to most reported Shy-Drager patients who had parkinsonism in varying degrees as the major feature2'3. Selective vulnerability in multiple system atrophy undoubtedly occurs but its basis remains unclear.
Though unrecognized in this patient, abductor paralysis of the vocal cords is now an established feature of the syndrome2. Varying in degree, it is usually bilateral and can precede the appearance of both autonomic and extrapyramidal dysfunction10.
Speech changes were reported to occur in over half of the patients3 and could aid in the clinical differentiation between patients with pure autonomic dysfunction and those with central neurological involvement as well4. These were apparently not taken note of in this case. Sleep apnoea was described to be not uncommon in Shy-Drager patients26. Its absence despite the obvious airway obstruction in this as well as 9 out of 11 patients with vocal cord paralysis2 indicated the probably important role of disorganization of central respiratory control in the aetiology of apnoeic episodes11. The reductions in total sleep time, slow wave and rapid eye movement sleep in this patient had been similarly reported before but their specificity and significance remain unclear. 0141-0768/89/ 040225-02/$02.00/0 X1989 The Royal Society of Medicine Although mental deterioration was originally said to be absent', there have been recent reports of psychiatric presentations, such as depression and subcortical dementia74.
These do not seem surprising in view of the many subcortical structures that are at risk of degeneration in the Shy-Drager syndrome. Indeed, its overlap of symptomatology with depression (loss of libido, impotence, fatiguability, apathy, reduced sleep, inability to work, social withdrawal) and the possible failure of non-psychiatric doctors to elicit psychiatric symptoms'2 could have contributed to underdiagnosis in the past. Misdiagnosis as neurosis has also been reported'3.
The need for careful clinical assessment and interdisciplinary cooperation is clear.
By March 1987, 31526 adult cases of acquired immune deficiency syndrome (AIDS)1 had been reported in the USA and 456 paediatric cases. In the UK, 750 cases were reported but 25 times this number are human immunodeficiency virus (HIV) positive and it is estimated that approximately 12% of those seropositive will go on to develop AIDS.
Kaposi's sarcoma is the presenting feature ofAIDS in over a quarter of homosexual men and occurs in upto 45% of homosexual AIDS patients, although it is present in less than 10% of other risk groups. Kaposi's sarcoma alone has the best prognosis; the median survival for patients with AIDS Kaposi's sarcoma2 is 21.2 months in the absence of opportunistic infections and 12.5 in those with Pneumocystis carinii and 6.6 months in those with both. We would like to report two homosexual patients with Kaposi's sarcoma who illustrate the potentially long survival of such patients.
Case reports Case 1 Presented in 1980 with Kaposi's sarcoma on the left leg. A venogram suggested involvement of the left calf veins and lymphocyte studies showed an increased suppressor cell population. He was irradiated with a long field from the mid-thigh to the toes using 8 MeV electrons and received 22.5 Gy in 10 daily fractions. In 1985 he developed a new Kaposi's sarcoma on the same leg managed by excision biopsy followed by radiotherapy. Human T-cell lymphotropic virus (HTLV E) was equivocal. He received 2o Gy using 5 MeV electrons in 10 fractions.
A month later a repeat HTLV m was positive, his helper/suppressor ratio was reversed and he had developed Kaposi's sarcoma ofthe scrotum. These were irradiated using 20 Gy and a further 10 Gy to localized lesions. Later the same year he developed further lesions on the hands, palate and feet. The most troublesome lesions on the right foot and elbow were bleeding and therefore irradiated, both receiving 30 Gy although using different machines, numbers of fractions and overall time. All treated lesions regressed. In January 1986 a lesion was excised from the conjunctiva and Kaposi's sarcoma on the right alae nasii irradiated with 10 MeV electrons. In the same year various lesions on the hands were irradiated using 7 MeV electrons.
He now had widespread Kaposi's sarcoma but no evidence of opportunistic infections and his general condition is good.
Case 2: A 47-year-old practising homosexual presented in 1981 with Kaposi's sarcoma ofthe left foot. He had a past history ofhepatitis B, gonorrhoea and syphilis and a history of amyl nitrate inhalation. The lesion was managed by excision biopsy and a further Kaposi's sarcoma lesion excised in 1982. In 1983 he presented with an isolated new nodule on the left foot and this was irradiated and received a cancerocidal dose of 50 Gy using 5 MeV electrons in 10 daily fractions. He had no evidence of opportunistic infections. Absolute numbers of helpers and suppressors were normal with a ratio of 1.25. He remained well subsequently with no evidence ofrecurrent Kaposi's sarcoma. In 1984 HTLV m was negative but in October 1986 this was positive with an increased number of suppressor cells and a helper to suppressor ratio of 0.46.
These two patients are interesting for a variety of reasons. Their long survival, as an illustration ofthe radiosensitivity of Kaposi's sarcoma in AIDS patients and the usefulness of radiotherapy as a technique to control troublesome lesionsconfirmed by other authors3
Multiple disease sites were treated and required variable doses. Response rates varied within and between individuals and this may reflect an altered response to radiation because of changes in the immune status. Both patients showed a deterioration of their helper to suppressor ratio, both had increased suppressor cell numbers and Kaposi's sarcoma antedated the development ofHIV positivity. Solitary lesions often have long relapse free intervals and seem to have a better prognosis. Whether these patients constitute part of 0141-0768/89/ 040226-02/$02.00/0 ©1989 The Royal Society of Medicine
